Work begins on Royal Bolton Hospital's maternity wing to replace RAAC
Officials confirmed the presence of RAAC at the hospital's maternity and women's health unit in 2023.
The lightweight material was seen as a cheaper alternative to regular concrete and often used in construction between the 1950s and 1990s.
Its airy nature led to an expected lifespan of around 30 years, with hundreds of schools and public buildings now suffering crumbling walls, floors and roofs.
All carry the risk of moisture seeping into the RAAC and causing it to collapse.
Tyrone Roberts, the chief nursing officer at Bolton NHS Foundation Trust, said: 'This is a really exciting time for maternity and women's health services here in Bolton – the first steps in what will be a fantastic development for families now and for many future years to come.
'We're looking forward to the families of Bolton and beyond starting their journeys together in a modern environment that will be fit for not only them, but future generations.'
The project will take place across different stages to make sure there is no loss of service in maternity, antenatal and postnatal care, with the hospital promising it will deliver 'modern facilities' for local families.
Work will also take place to refurbish the hospital's operating theatres, upgrading mechanical ventilation systems, and installing new rooftop plant machinery.
Elliot Robertson, the CEO of Robertson Group who will undertake the renovation, said: 'This marks an important step forward not just in addressing the immediate challenges posed by RAAC, but in creating modern, safe, and welcoming healthcare environments that will serve generations to come.
'We are working in close partnership with the NHS to deliver high-quality space that enable staff to focus on what matters most – patient care.
'It's a privilege to support Bolton NHS Foundation Trust on such a vital transformation.'
There are 47 hospitals across England with RAAC confirmed in their buildings, with the government allocating £954 million to help tackle the problem since the 2021/22 financial year.
Five other hospitals in Greater Manchester are in the national programme to tackle RAAC- Salford Royal, the Royal Oldham, Leigh Infirmary, Wythenshawe Hospital and North Manchester General.
A project to eradicate RAAC at Stepping Hill in Stockport was completed last year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
One in five NHS doctors considering leaving UK profession, report warns
The Government's pledge to cut hospital waiting lists is at risk unless more is done to retain doctors in the NHS, the medical regulator has warned. Almost one in five (19%) of doctors are considering quitting being a doctor in the UK, the General Medical Council (GMC) said. And one in eight (12%) are considering leaving the UK to work abroad, according to GMC figures. The main reason given for considering a move abroad was that doctors are 'treated better' in other countries, with an increase in pay cited as the second most common reason for plans to emigrate. Overall, some 43% of doctors told the GMC that they had researched career opportunities in other countries. Some 15% of doctors reported they had taken 'hard steps' towards leaving UK practice – such as applying for roles overseas or contacting recruiters. 'We must be alive to the ongoing risks to retention of doctors and the impact of losing talented staff,' the authors of the GMC's latest report wrote. 'This could threaten Government ambitions to reduce waiting times and deliver better care to patients.' Prime Minister Sir Keir Starmer has pledged that, by July 2029, 92% of patients will be seen within 18 weeks for routine hospital treatment such as hip and knee replacements. The GMC's latest report also raised concerns about career progression for medics. The report highlighted that 8% of doctors who felt they could progress their career said they were likely to leave the UK medical profession and had taken hard steps towards doing so, compared with 27% of those who did not feel this way. Overall one in three doctors said they are unable to progress their education, training and careers in the way they want, according to the report, which is based on responses from 4,697 doctors around the UK. It found that those who did not feel as though their careers were progressing the way they would wish were at higher risk of burnout and were less satisfied with their work. The GMC said that workloads, competition for posts, and lack of senior support for development are adversely impacting career hopes for UK doctors. Charlie Massey, chief executive of the GMC, said: 'Like any profession, doctors who are disillusioned with their careers will start looking elsewhere. 'Doctors need to be satisfied, supported, and see a hopeful future for themselves, or we may risk losing their talent and expertise altogether. 'Achieving this requires modernising the current training system, so it meets the needs of doctors and patients.' It comes as Health Secretary Wes Streeting and the British Medical Association are locked in talks to avert further strike action by resident doctors after a five-day walkout in July. Resident doctors, formerly known as junior doctors, are in a dispute with the Government over pay and a lack of places for doctors in training. Commenting on the GMC report, Billy Palmer, senior fellow at the Nuffield Trust think tank, said: 'Pay and industrial action have been a lightning rod for dissatisfaction among doctors but this survey puts a spotlight on the wider difficulties facing the medical profession. 'Job guarantees, better rotas and placements, and protection of training time all need to be on the table. 'Addressing the burden of medical graduates' student debt by gradually writing off loans could also be a promising way to reward doctors' NHS service. With fewer than three in five doctors in 'core training' remaining in the NHS eight years later, unless warnings from this survey are dealt with, we'll continue to lose these skilled clinicians.' A Department of Health and Social Care spokesperson said: 'The findings in this report are further evidence of what we know, that after more than a decade of neglect, doctors have legitimate complaints about their conditions, including issues with training bottlenecks and career progression. 'We want to work with them to address these and improve their working lives, which includes our plans set out in the 10 Year Health Plan to prioritise UK graduates and increase speciality training posts. 'This Government is committed to improving career opportunities and working conditions, bringing in ways to recognise and reward talent – as well as freeing up clinicians' time by cutting red tape.'
Yahoo
13 hours ago
- Yahoo
Talking therapy for depression and anxiety ‘less effective for young adults'
NHS talking therapies for depression and anxiety appear to be less effective for young adults, according to new analysis. Younger people may find it 'harder to navigate services set up for adults' – with attendance to therapy sessions hampered by stressful life events in the late teens and early 20s, experts suggest. Researchers warned there is an 'urgent need' to ensure the best possible mental healthcare for people aged 16-25 amid rising rates of mental health conditions. NHS talking therapy for conditions like anxiety and depression can include cognitive behavioural therapy (CBT), counselling, and guided self-help using workbooks or online courses. To explore ways in which services could be tailored to younger people, experts from University College London (UCL) analysed data from 1.5 million people who had attended NHS talking therapies in England between 2015 and 2019, including more than 309,758 people aged between 16 and 24. Using self-reported scores from questionnaires taken before and after treatment, researchers found younger adults were 25% less likely to meet the threshold for reliable recovery after having talking therapy. They were also 17% less likely to meet criteria for reliable improvement when compared to those aged 25-65. Professor Argyris Stringaris, of UCL psychiatry, suggested people aged 16-24 may find it harder to regularly attend therapy sessions. He said: 'Young people may find it harder to navigate services which have been set up for adults, and are more likely to miss sessions or stop attending altogether. 'Additionally, the late teens and early 20s are a point of transition for many people, which can involve plenty of stressful life events and changes that may make it more difficult to consistently attend. 'Working together with young people should help optimise the content of treatment and the ways in which it is delivered. 'Finally, young people may suffer from depression and anxiety problems that may differ somehow in their causes from those affecting adults; early onset depression could have different causes and may require different approaches to treatment. This is an area that requires a lot of new basic and clinical research.' Researchers said the findings, published in Lancet Psychiatry, suggest future studies should consider tailoring mental health services to young people. Dr Rob Saunders, of UCL psychology and language sciences, said: 'Talking therapy is an effective treatment for depression and anxiety disorders, and particularly tends to be preferred to pharmacological treatment by younger adults. 'Our analysis shows that talking therapies offered by the NHS are effective for younger adults, but as they are more effective for working-age adults, we believe there is work to be done to improve services for young adults. 'Rates of depression and anxiety in young adults are rising, so there is an urgent need to ensure we are offering them the best possible mental health care.' The latest Adult Psychiatric Morbidity Survey, published in June, found more than a quarter of people aged 16-24 reported having so-called 'common mental health conditions', which include generalised anxiety disorder, depressive episodes, phobias, obsessive compulsive disorder (OCD) and panic disorder. The figure was up from 17.5% in 2007. An NHS spokesperson said: 'This study finds talking therapy is still helpful for young people and so we would urge them to come forward for care with our world-leading talking therapies service which provides evidence-based mental health support to more than a million people a year, with nine in 10 patients receiving support within six weeks.' Olly Parker, head of external affairs and research at the charity YoungMinds, said: 'Growing up today is incredibly tough. 'Many young people are experiencing multiple pressures which impact their mental health, including poverty, inequality, intense academic pressure, and the online world. It's no wonder so many are struggling. 'We know many young people face long waits for mental health support and become more unwell while waiting, which can lead to needing more urgent care. We need to take an evidence-led approach to getting support right, ensuring young people are involved in choosing the treatments that work best for them. 'These findings must serve as another wake-up call to Government that urgent action is needed to reverse the decline in young people's mental health. This looks like a cross-government response that asks why so many young people are struggling, with radical solutions to address these root causes of poor mental health.'
Yahoo
15 hours ago
- Yahoo
Patients whose lives were ruined after being ‘needlessly given cancer drug for years' sue NHS trust
More than 20 patients who say their quality of life was wrecked when they were needlessly given a highly toxic cancer drug are suing the NHS trust involved. Some people were prescribed temozolomide – which should normally be used for only six months – for more than a decade during treatment by the University Hospitals Coventry and Warwickshire NHS Trust. They say the overprescribing left them with side-effects including secondary cancers and crippling fatigue. Earlier this year the Care Quality Commission was looking into at least 14 cases, but lawyers say more are emerging all the time. An investigation by lawyers Brabners found that, over the past two decades, numerous patients with brain and spinal tumours under the care of Professor Ian Brown were routinely exposed to prolonged and in some cases 'unnecessary' use of the chemotherapy drug, which has severe side-effects including extreme fatigue, confusion, sickness and seizures. The time periods temozolomide was given for allegedly ran contrary to medical and scientific guidelines. Standard NHS procedure is to use the drug over six months, and the drug manufacturer advises it be used for up to 12 months. One man said he was prescribed it for nearly two years longer than necessary, suffering extreme fatigue and low mood as a result. A woman in her twenties said she was misdiagnosed with cancer, receiving the drug needlessly for about eight years. Some patients are now having treatment for secondary cancers allegedly linked to overuse of temozolomide, the lawyers claim. Others claimed its prolonged use left them unable to pursue career ambitions and normal day-to-day activities because the chemotherapy was debilitating, with a long recovery time. Some reported loss of fertility or abnormal blood test results. The legal team says data shows that the trust's spending on the drug of £3.6m from 2009 to 2024 is 10 times that of other NHS oncology departments. The lawyers are now calling for an extended patient safety review and independent investigation, focusing in particular on treatment received by patients under Prof Brown dating back to 2006. The trust has been conducting an internal patient safety review, covering 2017 to 2023, when Prof Brown retired. A patient who identified only as Michael received an extra 22 cycles of temozolomide at the trust, despite his scans being stable. Prof Brown was not present during consultations, and Michael said he was always seen by a clinical nurse specialist. After suffering extreme fatigue and low mood, he learnt through news reports of mistreatment –not from the trust – that he should not have remained on treatment for so long, according to his lawyers. Another patient, identified only as Becky, says she received at least 100 cycles of the drug unnecessarily after being misdiagnosed with a brain tumour. Fiona Tinsley, head of medical negligence at Brabners, said: 'The extent of this scandal, and the physical and mental impact it has had on Prof Brown's patients cannot be underestimated.' She added: 'We believe there are many more patients out there who haven't yet come forward and some who may have sadly passed away. 'While we welcome the ongoing investigations being undertaken by the General Medical Council and Royal College of Physicians, we believe a full independent inquiry is necessary – including an extension of the trust's own review back to 2006 – not only to ensure justice for victims, but that processes are put in place to better identify and prevent such failings happening again.' A spokesperson for the trust told The Independent: 'We have comprehensively reviewed and spoken to all individuals who were receiving temozolomide (TMZ) treatment at the end of 2023 to ensure appropriate support and care plans are in place. 'A glioblastoma is an aggressive brain tumour with fewer than two per cent of patients surviving longer than 10 years. This is an extremely complex condition and all modes of treatment – surgery, chemotherapy and radiotherapy – carry the risk of complications and side-effects. 'National Institute for Health and Care Excellence (Nice) guidelines recognise that clinicians can exercise professional judgment appropriate to individual circumstances when offering treatment to patients. 'We have commissioned the Royal College of Physicians to conduct an independent review of a representative cohort of patients who received greater than 12 cycles of adjuvant TMZ between 2017 and 2023. 'As this process is ongoing, it would be inappropriate to comment further at this stage." It's understood that CQC inspectors have been in touch with the trust to understand the details, and seek assurances that patients are not at risk. The regulator will be reviewing more information to judge whether it needs to be involved. Solve the daily Crossword
